Greece set for further price cuts
August 23, 2010Sales and Marketing Greece
The Greek government is set to impose price cuts of more than 10% and will further cut reimbursement for a …
Hospital consultants’ bonuses to be reviewed
August 23, 2010Sales and Marketing NHS, consultants
NHS consultants could soon be among those to feel the sting of government cutbacks, according to the secretary of state …
Roche to acquire digital pathology specialists
August 23, 2010Research and Development, Sales and Marketing Diagnostics, Roche
Roche has added to its portfolio of diagnostics products by acquiring US company BioImagene. The privately held Californian company specialises …
Cohn & Wolfe wins MS account
August 20, 2010Medical Communications Cohn & Wolfe, Genzyme, MS
Cohn & Wolfe has won a global account with Genzyme to handle communications for its work with alemtuzumab in multiple …
Pharma sector a ‘market for lemons’
August 20, 2010Sales and Marketing NICE, health economics
American sociologist Donald Light has made a provocative assessment of the pharma industry, saying the industry is able to exaggerate …
Benlysta to be fast-tracked by FDA
August 20, 2010Sales and Marketing Benlysta, GSK, HGS, Lupus
New lupus drug Benlysta has been given priority review status by the FDA.Benlysta (belimumab) has been developed by Human Genome …
Kowa launches new statin in the UK
August 20, 2010Sales and Marketing Kowa, Recordati, cv, statin
A new statin has been launched in the UK by Japanese pharma company Kowa.Livazo (pitavastatin) has been approved by the …
Rupert Potter joins Incuna
August 20, 2010Medical Communications, Sales and Marketing Incuna, appointment, medical communications, sales and marketing
Rupert Potter has been appointed sales director at digital agency Incuna, where he will be responsible for a number of key …
ASCO 2010: The Hedgehog Pathway and other ways to target cancer
August 19, 2010Research and Development ASCO, Cancer, thyroid cancer
The American Society of Clinical Oncology conference, one of the most important dates in the pharmaceutical industry’s calendar, took place …
Chris Hare appointed new Managing Director of Woolley Pau
August 19, 2010Medical Communications Woolley Pau, appointment, medical communications
Chris Hare, former vice president of international client services at GyroHSR, has been appointed managing director of Woolley Pau. He …
Novartis and Quark sign gene silencing deal
August 19, 2010Research and Development Novartis, Quark, SiRNA, rnai
Novartis has joined the race to develop a ‘gene silencing’ treatment by signing a new deal with siRNA specialist Quark …
BMS’ melanoma drug given priority review
August 19, 2010Sales and Marketing BMS, ipilimumab
Bristol-Myers Squibb’s promising new treatment for skin cancer melanoma has been given a priority review by the FDA. The company …
Cell therapy industry partnership launched
August 18, 2010Research and Development Genzyme, ISCT, Lonza, Roche
Pharma and biotech companies including Roche and Genzyme are to launch a series of initiatives to bolster progress in the …
Contract research news in brief
August 18, 2010Research and Development Anavex, Cyprotex, Synexus
UK contract research organisation Synexus says it is reaping the benefits of its investments in Hungary in recent years, with …
FDA already notified on ProAmatine withdrawal, says Shire
August 18, 2010Sales and Marketing FDA, ProAmatine, Shire
Shire is to withdraw its product ProAmatine following a demand from the FDA early this week regarding post-marketing data on …
Lilly abandons late stage Alzheimer’s drug
August 17, 2010Research and Development Alzheimer's, lilly
Lilly is to abandon an Alzheimer’s drug in phase III development after results suggested it actually accelerated the disease rather …
BAC and Octapharma extend collaboration for G-CSF custom ligand
August 17, 2010Manufacturing and Production BAC, Octapharma
BAC, a specialist in antibody-based affinity purification technology has signed a licence agreement with Octapharma, which manufactures human proteins for …
FDA considers pulling ProAmantine
August 17, 2010Sales and Marketing FDA, Shire, post-marketing
Shire’s low blood pressure drug ProAmantine and generic copies could be withdrawn from the US market because no post-marketing studies …
AstraZeneca staff to strike over pension cuts
August 17, 2010Sales and Marketing AstraZeneca, pensions
AstraZeneca is reviewing its position after UK trade union members at the company voted to strike over cuts to pension …
Digital Pharma: Roche asks employees to be social media ‘scouts’
August 17, 2010Medical Communications Digital Pharma blog, Roche, social media
Roche wants employees who use social media to be ‘scouts’ for how the company and its products are perceived online. …
Latest content
Brenntag and dsm-firmenich expand biopharma vitamin partnership
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
